Lipigon Pharmaceuticals AB:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Lipigon Pharmaceuticals AB - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C11221
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:17
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:スウェーデン
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Lipigon Pharmaceuticals AB (Lipigon Pharmaceuticals) is a lipid biology company that discovers and develops novel therapies for lipid disorders and other cardiometabolic risk factors. The company offers developing its products in various therapeutic areas such as cardiovascular and metabolic disorders. It discovers small molecule activators of lipoprotein lipase. Lipigon Pharmaceuticals’ lead product candidate is designed to significantly lower the elevated levels of TG, raise levels of HDL and improve other cardiometabolic risk factors. The company partners with other pharmaceutical companies to develop new projects. Lipigon Pharmaceuticals is headquartered in Umea, Sweden.

Lipigon Pharmaceuticals AB – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Lipigon Pharmaceuticals AB, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Lipigon Pharmaceuticals AB, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Lipigon Pharmaceuticals AB, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Lipigon Pharmaceuticals AB, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Lipigon Pharmaceuticals AB, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Lipigon Pharmaceuticals AB, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
Lipigon Pharma Enters into Agreement with Secarna Pharma 10
Lipigon Pharma Enters into Research Agreement with AstraZeneca 11
Lipigon Pharma Enters into Research Collaboration Agreement with AstraZeneca 12
Lipigon Pharmaceuticals AB – Key Competitors 13
Lipigon Pharmaceuticals AB – Key Employees 14
Lipigon Pharmaceuticals AB – Locations And Subsidiaries 15
Head Office 15
Recent Developments 16
Corporate Communications 16
Apr 06, 2017: Lipigon Pharmaceuticals announces new appointed members of the board – Gisela Sitbon and Erik Lund 16
Appendix 17
Methodology 17
About GlobalData 17
Contact Us 17
Disclaimer 17

List of Tables
Lipigon Pharmaceuticals AB, Pharmaceuticals & Healthcare, Key Facts 2
Lipigon Pharmaceuticals AB, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Lipigon Pharmaceuticals AB, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Lipigon Pharmaceuticals AB, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Lipigon Pharmaceuticals AB, Deals By Therapy Area, 2012 to YTD 2018 8
Lipigon Pharmaceuticals AB, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Lipigon Pharma Enters into Agreement with Secarna Pharma 10
Lipigon Pharma Enters into Research Agreement with AstraZeneca 11
Lipigon Pharma Enters into Research Collaboration Agreement with AstraZeneca 12
Lipigon Pharmaceuticals AB, Key Competitors 13
Lipigon Pharmaceuticals AB, Key Employees 14

List of Figures
Lipigon Pharmaceuticals AB, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Lipigon Pharmaceuticals AB, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Lipigon Pharmaceuticals AB, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Lipigon Pharmaceuticals AB, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Lipigon Pharmaceuticals AB, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Lipigon Pharmaceuticals AB, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Lipigon Pharmaceuticals AB, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Lipigon Pharmaceuticals AB, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Lipigon Pharmaceuticals AB:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Otter Tail Corp:企業の発電所・SWOT分析2018
    Otter Tail Corp - Power Plants and SWOT Analysis, 2018 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employees (ex …
  • A-Mark Precious Metals Inc (AMRK):企業の財務・戦略的SWOT分析
    A-Mark Precious Metals Inc (AMRK) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • Karntner Elektrizitats-Aktiengesellschaft:企業の戦略的SWOT分析
    Karntner Elektrizitats-Aktiengesellschaft - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and …
  • Ashtead Group Plc (AHT):企業の財務・戦略的SWOT分析
    Ashtead Group Plc (AHT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Indoco Remedies Ltd (INDOCO):製薬・医療:M&Aディール及び事業提携情報
    Summary Indoco Remedies Ltd (Indoco Remedies) is a research-oriented pharmaceutical company that manufactures and markets formulations (finished dosage forms) and active pharmaceutical ingredients (APIs). It has products portfolio in various therapeutic segments such as cardiovascular, central nervo …
  • Endo International Plc (ENDP):企業の財務・戦略的SWOT分析
    Endo International Plc (ENDP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Alfa SAB de CV (ALFAA):石油・ガス:M&Aディール及び事業提携情報
    Summary Alfa SAB de CV (Alfa) is a diversified company that operates in the petrochemical, refrigerated food, lightweight solutions, telecommunication, and oil and gas sectors. Alfa develops and manufactures high technology aluminum components for the power train and body structure of automotive. It …
  • Tivoli A/S
    Tivoli A/S - Strategy, SWOT and Corporate Finance Report Summary Tivoli A/S - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • PhoreMost Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary PhoreMost Ltd (PhoreMost) is a drug discovery company that develops drugs for the treatment of cancer. The company's lead drug discovery program is based on a novel target, which tackles the undruggable cancer gene KRAS that affects various types of cancer. It develops Site-Seeker, a platfor …
  • Zynex Inc (ZYXI):企業の財務・戦略的SWOT分析
    Summary Zynex Inc (Zynex), formerly Zynex Medical Inc is a medical technology company that designs, manufactures, and markets electrotherapy medical devices used for pain management and rehabilitation. The company’s products include NexWave, a dual channel, multi-modality interferential current, tra …
  • Polaris Industries Inc (PII):企業の財務・戦略的SWOT分析
    Polaris Industries Inc (PII) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Valero Energy Corp (VLO):企業の財務・戦略的SWOT分析
    Valero Energy Corp (VLO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Larsen & Toubro Ltd (LT):電力:M&Aディール及び事業提携情報
    Summary Larsen & Toubro Limited (L&T) is an industry conglomerate. It carries out technology, engineering, construction and manufacturing activities. The company offers a broad spectrum of design-to-deliver solutions. Its service portfolio includes basic and detailed engineering, erection and commis …
  • Data Respons ASA (DAT):企業の財務・戦略的SWOT分析
    Summary Data Respons ASA (Data Respons) is an information technology company that offers software products and embedded solutions. The company's products include storage and memory, handheld tablets, embedded boards, panel PCs and displays, systems and platforms, and industrial communication product …
  • Genting Bhd (GENTING):電力:M&Aディール及び事業提携情報
    Summary Genting Bhd (Genting) is an investment holding and management company. The company operates through its subsidiaries in leisure, hospitality, gaming, entertainment, property development and operation, oil and gas, power generation and palm oil plantation sectors. It manages a portfolio of ho …
  • Falcon Oil & Gas Ltd (FO):石油・ガス:M&Aディール及び事業提携情報
    Summary Falcon Oil & Gas Ltd (Falcon), formerly Sanfred Resources Ltd., is a global energy company. It carries out acquisition, exploration and development of large acreage positions of conventional and unconventional oil and gas resources. The company holds interests three major exploration project …
  • Adamis Pharmaceuticals Corp (ADMP):企業の財務・戦略的SWOT分析
    Summary Adamis Pharmaceuticals Corp (Adamis), formerly Cellegy Pharmaceuticals Inc, is a biopharmaceutical company that develops therapies in areas of respiratory disease and allergy. The company offers pipeline product, epinephrine pre-filled syringe is developed for anaphylactic reactions such as …
  • Massachusetts Institute of Technology-製薬・医療分野:企業M&A・提携分析
    Summary Massachusetts Institute of Technology (MIT) is a research university that provides contract research and education. The institute offers education in the areas of computer science, biology, aeronautics, mechanical engineering, civil engineering, economics, electrical engineering, literature, …
  • Country Road Group Pty Ltd:企業の戦略的SWOT分析
    Country Road Group Pty Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Nuformix Ltd-製薬・医療分野:企業M&A・提携分析
    Summary Nuformix Ltd (Nuformix) is a provider of pharmaceutical cocrystallisation products. The company develops and manufactures products in reprofiling, supergenerics and emerging markets areas. It offers methodologies for rational solid form discovery; and provides technologies for rapid solid fo …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆